Companies

Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.

Centerpoint Energy Inc
CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio. The company has natural gas distribution systems in six states serving approximately 4 million customers. After exiting its midstream investment, CenterPoint is a fully regulated utility.
CNP
Centerra Gold Inc.
Centerra Gold Inc. is a Canadian-based gold mining company focused on operating, developing, exploring and acquiring gold and copper properties in North America, Türkiye, and other markets worldwide. Centerra operates two mines: the Mount Milligan Mine in British Columbia, Canada, and the Öksüt Mine in Türkiye. The Company also owns the Goldfield District Project in Nevada, United States, the Kemess Project in British Columbia, Canada, and owns and operates the Molybdenum Business Unit in the United States and Canada. Centerra's shares trade on the Toronto Stock Exchange ('TSX') under the symbol CG and on the New York Stock Exchange ('NYSE') under the symbol CGAU. The Company is based in Toronto, Ontario, Canada.
CGAU
Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment, and it owns properties in the following states: Minnesota, Colorado, North Dakota, Nebraska, South Dakota, and Montana. Rental income represents the company's main source of revenue, and properties owned in Minnesota, Colorado, and North Dakota represent the majority of the firm's commercial presence.
CSR
Centessa Pharmaceuticals Plc
Centessa Pharmaceuticals PLC is a pharmaceutical company. Its portfolio consists of preclinical to phase 3 uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. Some of its products include Vasopressin V2 Receptor Inhibitor (Lixivaptan), BMP9 Engineered Variant (MGX292), OX2R Agonist (Oral) among others.
CNTA
Centogene N.v.
CENTOGENE engages in diagnosis and research around rare diseases transforming real-world clinical genetic and multiomic data to diagnose understand and treat rare diseases. Our goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our extensive rare disease knowledge and data. CENTOGENE has developed a global proprietary rare disease platform based on our real-world data repository of over 650000 individuals representing over 120 different countries. The Companys platform includes epidemiologic phenotypic and genetic data that reflects a global population as well as a biobank of patients blood samples and cell cultures. CENTOGENE believes this represents the only platform focused on comprehensive analysis of multi-level data to improve the understanding of rare hereditary diseases.
CNTGF
Central & Eastern Europe Fund, Inc.
Central Europe & Russia Fund Inc is a closed end management investment company. Fund Investing in foreign securities presents certain risks, such as currency fluctuations, political and economic changes, and market risks. Emerging markets tend to be more volatile and less liquid than the markets of more mature economies, and generally have less diverse and less mature economic structures and less stable political systems than those of developed countries. Any fund that focuses in a particular segment of the market or region of the world will generally be more volatile than a fund that invests more broadly. This Fund is non-diversified and can take larger positions in fewer issuers, increasing its potential risk.
CEE
Central Garden & Pet Co
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. Central is on a mission to lead the future of the pet and garden industries. The company's innovative and trusted products are dedicated to help lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, strong manufacturing and distribution capabilities, and passionate, entrepreneurial growth culture. Central Garden & Pet is based in Walnut Creek, California, and has offices across North America and Europe.
CENT
Central Japan Railway Co
Central Japan Railway Co. provides rail transportation services between Tokyo and Osaka, including the Tokai region. The company, through its subsidiaries, also provides bus transportation services, leases real estate, and operates department stores, hotels, restaurants, and construction businesses.
CJPRF
Central North Airport Group
Grupo Aeroportuario del Centro Norte operates airports in the central region of Mexico. The largest airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park.
OMAB
Central Pacific Financial Corp
Central Pacific Financial Corp operates in the financial services sector in the United States. It acts as a holding company for Central Pacific Bank, through which it provides a range of banking products and services. It caters to businesses, professionals, and individuals through an array of loan products, including residential mortgage loans, commercial and consumer loans and lines of credit, commercial real estate loans and construction loans. Apart from its predominant banking segment, it also functions through a Treasury segment, which is responsible for managing the company's investment securities portfolio and wholesale funding activities.
CPF
Central Pattana Public Co Limited
No description
CPPBY
Central Plains Bancshares, Inc.
Central Plains Bancshares, Inc. (the 'Company'), the holding company for Home Federal Savings and Loan Association of Grand Island, which operates under the name 'Home Federal Bank' (the 'Bank'), announced today that it has completed the initial public offering in connection with the Bankâs conversion from the mutual form of organization to the stock form of organization.
CPBI
Central Puerto S.a.
Central Puerto SA is a private sector power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. Its operating segment includes Electric Power Generation from conventional sources; Electric Power Generation from renewable sources; Natural Gas Transport and Distribution and others. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
CEPU
Central Retail Corp Public Co Limited
No description
CLRLY
Central Securities Corp
Primary investment objective is growth of capital. Income received from securities is a secondary consideration.
CET
Centrus Energy Corp
Centrus Energy Corpis engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides advanced engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue gets derived from the LEU segment.
LEU
Centuri Holdings, Inc.
Centuri is a strategic infrastructure services company that partners with regulated utilities to build and maintain the energy network that powers millions of homes and businesses across the U.S. and Canada. Guided by our values and unwavering commitment to serve as long term partners to customers and communities, Centuri's more than 12,000 employees enable our customers to safely and reliably deliver electricity and natural gas as well as achieve their goals for environmental sustainability. Centuri is a subsidiary of Southwest Gas Holdings, Inc.
CTRI
Centurion Acquisition Corp.
No description
ALF
Century Aluminum Co
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.
CENX
Century Casinos Inc
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurant, horse racing and entertainment facilities primarily in North America. It has casinos in USA, Century Casino & Hotel - Colorado; Mountaineer Casino, Racetrack & Resort - West Virginia; Century Casino Cape Girardeau, and Century Casino Caruthersville - Missouri; Canada, Century Casino & Hotel; Century Casino St. Albert, and Century Mile Racetrack and Casino - Edmonton; Century Downs Racetrack and Casino, Century Sports, and Century Bets! Inc - Calgary; and Casinos Poland in Poland.
CNTY
Century Communities, Inc.
Century Communities Inc is a construction company that focuses on the residential market. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its own sales representatives and independent real estate brokers. It also advertises directly to potential homebuyers through the Internet, newspapers, and trade publications. The company generates the most revenue from the Mountain segment.
CCS
Century Therapeutics, Inc.
Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a plays a central role in the production of blood cells in the bone marrow. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.
IPSC
Ceragon Networks Ltd
Ceragon Networks Ltd offers wireless backhaul solutions. Its products comprise of FibeAir IP-20 Platform, FibeAir IP-20 Assured Platform, and Network Management. The company provides its services to wireless service providers, public safety organizations, government agencies and utility companies. The company's FibeAir IP-20 platform offers flexibility in choosing all-outdoor, split-mount and all-indoor configurations to suit any deployment scenario. Its products include short haul-access, short haul-aggregation, small cells, long haul, and enterprise access. Geographically, it derives majority revenue from India and also has a presence in North America, Europe, Africa, Asia-Pacific, and the Middle East and Latin America.
CRNT
Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all major automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, Middle East and Africa; Japan and Other Asia-Pacific.
CRNC
Ceribell, Inc.
CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting. The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients.
CBLL
Cero Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company's proprietary approach to T cell engineering, enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, which is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its cellular immunotherapy platform is focused on redirecting patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating CERo, which is referred to as chimeric engulfment receptor t cells (CER-T). The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies.
CERO
Certara, Inc.
Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States.
CERT
Cerus Corp
Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
CERS
Cervomed Inc.
CervoMed Inc. is a clinical-stage biotechnology company focused on developing treatments for age-related neurologic disorders. It is focused on the development of its lead drug candidate, neflamapimod, an investigational, orally administered, small molecule brain penetrant that inhibits p38a in the neurons (nerve cells) within the brains of people with neurodegenerative diseases. Its neflamapimod is in clinical development as a disease-modifying treatment for neurodegenerative diseases, such as dementia with Lewy Bodies and early Alzheimer's disease. In addition, pre-clinical data supports the potential role of neflamapimod in recovery after stroke. Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in dementia with Lewy bodies (DLB) and certain other neurological disorders.
CRVO
Ceva Inc
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.
CEVA